(CBAϫMus spretus)F 1 mice showed that most of the SCCs Loss of heterozygosity (LOH) at specific chromosomal loci analyzed had allelic imbalances throughout chromosomes 6, 7 is generally considered indirect evidence for the presence and 11. Allelic losses on chromosome 6 were also described of putative suppressor genes. Allelotyping of tumors using by our laboratory using (C57BL/6ϫDBA/2)F 1 hybrids (7). polymorphic markers distributed throughout the entire Our laboratory has been characterizing various inbred lines genome allows the analysis of specific allelic losses. In the derived from the outbred SENCAR stock and analyzing their field of chemical carcinogenesis, the outbred SENCAR differences in susceptibility to tumor progression (8-11). Using mouse has been commonly used to analyze the multistage the SSIN/Sprd and SENCARB/Pt mice, both inbred strains nature of skin tumor development. In the study reported derived from the outbred SENCAR stock that dramatically here we generated F 1 hybrids between two inbred strains differ in their susceptibility to skin tumor progression (SENCARB/Pt and SSIN/Sprd) derived from the SENCAR (10,12,13), we determined that tumor progression is under stock that differ in their susceptibility to tumor progression.
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genetic control and we have been working on the description We typed 24 7,12-dimethylbenz[a]anthracene and 12-Oof a genetic model and mapping of putative susceptibility tetradecanoylphorbol-13-acetate-induced squamous cell genes (M.C.Stern, F.Benavides, M.LaCava and C.J.Conti, in carcinomas for LOH using 56 microsatellite markers dispreparation). We screened the SSIN/Sprd (resistant for tumor tributed among all autosomal chromosomes. The highest progression) and SENCARB/Pt (susceptible for tumor progrespercentage of LOH, 78%, was found on chromosome 7, sion) mice with 453 microsatellite markers and found that 132 but there was no preferential loss of one particular allele, were polymorphic, with an average of 30% polymorphic indicating that the putative suppressor genes found in this loci (F.Benavides, M.C.Stern, E.Glasscock, L.G.Coghlan and area are not involved in genetic susceptibility. High levels C.J.Conti, in press). The goal of the present study was twoof LOH were also found on chromosomes 16 (39%), 6 fold: to determine the relevant genetic alterations in mouse (29%), 4 (25%), 9 (25%), 14 (22%), 10 (20%) and 19 skin carcinogenesis with the SENCAR background and to (20%), but with no preferential loss of the alleles of one determine whether there was a consistent loss of alleles from strain. The chromosomal regions with LOH on mouse either strain, which could suggest the presence of putative chromosomes 4, 6, 7, 9, 10, 14 conditions and that crosses can be arranged to maximize the Previous studies from our laboratory showed that in this CA) and incubated at room temperature for 15 min. Proteinase K (Sigma Chemical Co., St Louis, MO) was added to 0.2 µg/µl, with 1 h incubation at 55°C. Proteinase K was inactivated by boiling samples for 10 min. All tumors Abbreviations: DMBA, 7,12-dimethylbenz[a]anthracene; LOH, loss of heterozygosity; SCC, squamous cell carcinoma; TPA, 12-O-tetradecanoylphorbolwere typed by PCR using a panel of microsatellite repeats as described in Table I . Primers were obtained from Research Genetics (Huntsville, AL). 13-acetate. markers PCR was repeated and analyzed by a different person to validate our results. For some samples, sensitivity was improved using Vistra Green This is the first study done on SENCAR-derived strains that which allowed us to assume equal amounts of PCR products for each allele if no LOH had occurred. PCR products were resolved in 3.5-5% MetaPhor describes the possible involvement of other chromosomes gels (FMC, Rockland, ME) or non-denaturing 8-10% polyacrylamide gels besides 6 and 7 in the development of SCC and the analysis and stained with ethidium bromide. LOH was scored by comparing the results of allelic imbalances in two inbred SENCAR-derived strains.
of each SCC sample with standards that contained either 100% SSIN, 100%
These strains have become promising tools in future studies SENCARB/Pt or 50% SSIN-50% SENCARB/Pt. LOH was assigned whenever there was 50-100% loss of any one of the two alleles. For several critical in mouse skin carcinogenesis given their inbred condition and their different and well-characterized susceptibility to tumor gene. Analysis of LOH on mouse chromosome 6 on (C57BL/ 6ϫDBA/2)F 1 hybrids treated with a two-stage DMBA-TPA progression (10). In most cases we found that those regions with LOH corresponded to syntenic regions in the human protocol (7) showed that LOH occurred most frequently at two sites: D6Mit50 (3 cM), syntenic to human chromosome genome where LOH has been reported in a variety of tumors (Table II) . In particular, both areas of mouse chromosome 7 7; D6Mit29 (36.5 cM), syntenic to human chromosome 2. In the study reported here we also found two regions with LOH: with high LOH are syntenic to human chromosome 11, where at least one tumor suppressor gene has been suggested (15-D6Mit138, syntenic to human 7q21.3-q22; D6Mit39, syntenic to human 3p26-p24, a common region of deletions and allelic 19). It was shown that in head and neck SCC not only is 11q13 the most frequent breakpoint but also that this aberration losses in human tumors (Table II) . Chromosome 9 has been implicated in mouse islet cell tumors, where a putative supis a crucial determinant of tumor aggressiveness (20) . The previous data reported by our laboratory (5) and our present pressor gene, Loh1, has been mapped relatively close (53 cM) to D9Mit20 (61 cM), where we found 16% LOH. This LOH1 findings strongly suggest that there are at least two tumor suppressor genes involved in mouse skin tumor development marker shows a low rate of LOH in early stages of tumor formation but higher in the angiogenic islets (the end tumors), on the distal part of mouse chromosome 7. However, given that the H-ras gene maps at 72.2 cM, close to D7Mit223 (72.4 suggesting a role in tumor progression (21) . Interestingly, this region of human chromosome 9 is the only one that showed cM) where we found 52% LOH, it cannot be discarded that losses at this site could reflect a selection for cells that lost frequent LOH in both our study and an analysis of its syntenic region in human cutaneous SCC (22) . The area of chromosome the wild-type H-ras allele, rather than loss of a tumor suppressor (Table II) . 
